ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma

Recruiting

18 years - 99 years

All

Phase N/A

1000 participants needed

1 Location

Brief description of study

For subjects age 18 years and older who are at an increased risk for HCC and for whom HCC surveillance is appropriate, including subjects with cirrhosis or non-cirrhotic subjects with Hepatitis B. Approximately 3,000 subjects are expected to be enrolled, comprised of approximately 2,222 ultrasound surveillance subjects and 778 subjects under surveillance with CT/MRI.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Hepatocellular Carcinoma,Carcinoma,cirrhosis
Age: 18 years - 99 years
Gender: All

Male and Female Age 18 or older Diagnosis of cirrhosis

Updated on 04 Aug 2024. Study ID: 849567

Find a site

Your Information has been sent successfully.

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.

Would you like to be notified about other trials? Sign up for Patient Notification Services.

Send a message

Enter your contact details to connect with study team

Primary Contact

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Are you comfortable with the informed consent process?

Yes

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Brief description of study

Eligibility of study

Find a site

Interested in the study